TY  - JOUR

T1  - Validation of the comet-X assay as a pharmacodynamic assay for measuring DNA cross-linking produced by the novel anticancer agent RH1 during a phase I clinical trial.

JO  - Cancer Chemother Pharmacol

PY  - 2007/11/01

AU  - Danson S

AU  - Ranson M

AU  - Denneny O

AU  - Cummings J

AU  - Ward TH

ED  - 

DO  - DOI: 10.1007/s00280-007-0432-9

VL  - 60

IS  - 6

SP  - 851

EP  - 861

Y2  - 2024/09/19

ER  -